Clinical trial
Randomized, Double Blind,Saline-Controlled, Multi-Center, Prospective Study to Evaluate the Safety and Effectiveness of Carticept's Agilus Device for the Treatment of Ankle Osteoarthritis
NCT00642382 is registered in ClinicalTrials.gov with Cartiva, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double Blind,Saline-Controlled, Multi-Center, Prospective Study to Evaluate the Safety and Effectiveness of Carticept's Agilus Device for the Treatment of Ankle Osteoarthritis
- Lead sponsor
- Cartiva, Inc.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2008
- Completion date
- December 31, 2008
- Enrollment
- 17 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.